JULIUS CLINICAL – SCIENCE CONTRACT RESEARCH ORGANISATION
GLOBAL & FOCUSED
Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world. Our unique combination of scientific leadership and operational excellence ensures that the trial data is of the highest quality.
We specialise in distinct therapeutic areas including Brain Diseases, Infectious Diseases and Cardio Metabolic Diseases. We can offer a full-service proposal or separate functional services as required.
RWE
Dyslipidemia
NASH
RSV
Vaccines
ENT
ALS
Alzheimer’s Disease
𝗝𝘂𝗹𝗶𝘂𝘀 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗽𝗽𝗼𝗶𝗻𝘁𝘀 𝗠𝗮𝗿𝘁𝗶𝗷𝗻 𝗪𝗮𝗹𝗹𝗲𝗿𝘁 𝗮𝘀 𝗻𝗲𝘄 𝗖𝗘𝗢
After five years of dedication, Aize Smink, CEO of Julius Clinical the Science CRO, has decided to pursue new career opportunities. Julius Clinical is very grateful to Aize for his leadership and passion. Aize managed several major studies and expanded our portfolio to include new therapeutic domains and the inclusion of real world evidence and data science. He leaves Julius Clinical with a solid base for further growth and ready for new opportunities.
We are pleased to announce the appointment of Martijn Wallert as successor and Chief Executive Officer of the company. Martijn has worked for Julius Clinical in the past as Director Strategic Partners and, after advancing his career internationally, he will now bring his experience to step into the CEO position. We are confident that our clients and partners across the globe will welcome our new CEO and continue to collectively create research that impacts patients and society.
#juliusclinical #contractresearchorganization #cro #clinicalresearch